onQcare is a unique initiative that offers high-quality, holistic oncology solutions to cancer patients, through every step of their journey. Powered by QLabs Clinical Laboratory, onQcare aims to establish itself as the primary oncology care provider in the region.
At onQcare, we believe that the foundation of exceptional cancer care begins with precision diagnostics. Our mission is to provide comprehensive oncological solutions that empower physicians and patients to make informed decisions—before, during and after their cancer journey. From early risk assessment to diagnosis, treatment guidance, and post-treatment monitoring, onQcare stands as a trusted partner delivering innovation, reliability, and compassion.
Genetic Testing: Empowering Proactive Cancer Care
Our genetic testing solutions identify hereditary cancer syndromes, such as BRCA1/BRCA2 for breast and ovarian cancer and Lynch syndrome for colorectal and other cancers. These tests play a vital role in prevention and early detection, enabling high-risk individuals and their families to take proactive steps. By uncovering inherited genetic mutations, onQcare helps physicians tailor surveillance, screening, and treatment strategies to each patient’s unique risk profile.
Prognostic Testing in Early Breast Cancer: Confidence in Care Decisions
For patients with early-stage hormone receptor-positive breast cancer, onQcare offers evidence-based prognostic tests that assess the risk of cancer recurrence. These genomic assays provide critical insights into whether chemotherapy is truly needed—helping oncologists avoid overtreatment while ensuring those who would benefit from aggressive therapy receive it. This not only reduces unnecessary toxicity and cost but brings clarity and confidence to treatment planning.
Genomic Classifiers for Thyroid Nodules and Pancreatic Cysts: Reducing Uncertainty
Indeterminate thyroid nodules and pancreatic cysts often present diagnostic dilemmas. onQcare’s advanced genomic classifiers help distinguish between benign and malignant lesions with high accuracy, reducing the need for invasive procedures and uncertain watchful waiting. These tests transform ambiguity into actionable insights, streamlining management plans and improving patient outcomes.
Specialized Cancer Diagnostics: Precision for Every Case
Our portfolio extends to rare and aggressive cancers through cutting-edge technologies such as liquid biopsies, tumor profiling, and molecular assays. These tests aid in identifying targetable mutations, guiding immunotherapy decisions, and monitoring response to treatment. Whether it’s lung, gastrointestinal, or hematological malignancies, onQcare ensures patients receive the most personalized care possible.
A Partner Throughout the Journey
What sets onQcare apart is not just our scientific precision but our patient-centric approach. We understand that every cancer journey is personal – and complex, which is why we offer end-to-end support from test selection and logistics to interpretation and follow-up. Our team works closely with clinicians and healthcare institutions, providing education, clinical support, and data-driven insights to ensure timely and meaningful action.
Our home-collection services and quick, reliable reporting allow us to minimize delay in care. We aim to eliminate barriers and bring high-quality oncological diagnostics to every patient, by blending innovation with accessibility.
At onQcare, we don’t just deliver tests—we deliver trust, clarity, and compassionate care at every step.
To explore collaborations or learn more about how onQcare can support your organization or community, visit www.onqcare.online or call us at +971502840290
